ARA-290 dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Subcutaneous | 4 mg | Once daily · 28 days |
| Intravenous | 2 mg | 3 times weekly · 4 weeks |
ARA-290 dosage by administration route
ARA-290 injectable dosage
The documented subcutaneous ARA-290 schedule is 4 mg once daily for 28 days. Intravenous ARA-290 is given at 2 mg three times weekly for 4 weeks. An alternative schedule uses 4 mg subcutaneously once daily for four weeks, consistent with the 28-day subcutaneous schedule above. This does not change the separate intravenous amount or frequency.[1][2][3][8]
ARA-290 targets tissue-protective innate-repair signaling without stimulating red-blood-cell production. Its potential purpose concerns small-fiber neuropathy and corneal-nerve recovery.[1][2][3][4]
Frequency and timing
Take at a consistent time, usually morning or evening.[1]
ARA-290 dosage calculator
Convert your chosen ARA-290 amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
ARA-290 safety and side effects
Side effects and long-term safety
Local injection tolerance and repeat-course exposure are relevant. Durable safety after repeated or chronic use has not been established.[1][2][7][3]
Route-specific dosing limits
Tissue-protective signaling, EPO-pathway context, and chronic neuropathy use need disease-specific review. Additional schedules attributed to Everything Peptide are reported patterns; citing research does not make these schedules clinically established or approved product instructions.[2][4][8]
Common ARA-290 dosage questions
How do subcutaneous and intravenous ARA-290 doses differ?
When is ARA-290 administered?
Take at a consistent time, usually morning or evening.[1]
